Description
LABORATORY AUTOMATED IMMUNOASSAY INSTRUMENT. PO: 675C90142
Base award description: IGF::CT::IGF LABORATORY AUTOMATED IMMUNOASSAY INSTRUMENT
Modification chain · 12 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-03-25+$128,216= $128,216
- Mod P000012017-03-27+$12,488= $140,704
- Mod P000022017-03-30+$140,704= $281,408
- Mod P000032017-11-28-$1,408= $280,000
- Mod P000042017-12-08-$129,137= $150,862
- Mod P000052018-03-23+$139,296= $290,158
- Mod P000062018-05-23-$114,444= $175,714
- Mod P000072019-03-29+$127,560= $303,274
- Mod P000092019-09-13-$71= $303,203
- Mod P000082020-02-21+$136,659= $439,862
- Mod P000102020-06-02-$102= $439,760
- Mod P000112021-07-16-$411= $439,349
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-03-25 | +$128,216 | $128,216 | IGF::CT::IGF LABORATORY AUTOMATED IMMUNOASSAY INSTRUMENT |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2017-03-27 | +$12,488 | $140,704 | IGF::CT::IGF LABORATORY AUTOMATED IMMUNOASSAY INSTRUMENT |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2017-03-30 | +$140,704 | $281,408 | IGF::CT::IGF LABORATORY AUTOMATED IMMUNOASSAY INSTRUMENT |
| Mod P00003· OTHER ADMINISTRATIVE ACTION | 2017-11-28 | −$1,408 | $280,000 | IGF::CT::IGF LABORATORY AUTOMATED IMMUNOASSAY INSTRUMENT |
| Mod P00004· CLOSE OUT | 2017-12-08 | −$129,137 | $150,862 | IGF::CT::IGF LABORATORY AUTOMATED IMMUNOASSAY INSTRUMENT |
| Mod P00005· EXERCISE AN OPTION | 2018-03-23 | +$139,296 | $290,158 | IGF::CT::IGF LABORATORY AUTOMATED IMMUNOASSAY INSTRUMENT. PO: 675C80120 |
| Mod P00006· FUNDING ONLY ACTION | 2018-05-23 | −$114,444 | $175,714 | IGF::CT::IGF LABORATORY AUTOMATED IMMUNOASSAY INSTRUMENT. PO: 675C70145 |
| Mod P00007· EXERCISE AN OPTION | 2019-03-29 | +$127,560 | $303,274 | IGF::CT::IGF LABORATORY AUTOMATED IMMUNOASSAY INSTRUMENT. PO: 675C70145 |
| Mod P00009· OTHER ADMINISTRATIVE ACTION | 2019-09-13 | −$71 | $303,203 | LABORATORY AUTOMATED IMMUNOASSAY INSTRUMENT. PO: 675C70145 |
| Mod P00008· EXERCISE AN OPTION | 2020-02-21 | +$136,659 | $439,862 | LABORATORY AUTOMATED IMMUNOASSAY INSTRUMENT. PO: 675C90142 |
| Mod P00010· FUNDING ONLY ACTION | 2020-06-02 | −$102 | $439,760 | LABORATORY AUTOMATED IMMUNOASSAY INSTRUMENT. PO: 675C90142 |
| Mod P00011· FUNDING ONLY ACTION | 2021-07-16 | −$411 | $439,349 | LABORATORY AUTOMATED IMMUNOASSAY INSTRUMENT. PO: 675C90142 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI J49CN39QTNW3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526F0387 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $6,895 | FY2026 |
| 36C26226P1513 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $28,264 | FY2026 |
| 36C25726F0130 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 5860 · STIMULATED COHERENT RADIATION DEVICES, COMPONENTS, AND ACCESSORIES | $18,391 | FY2026 |
| 36C24126F0141 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $182,326 | FY2026 |
| 36C25626F0181 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $111,133 | FY2026 |
| 36C24126N0855 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,989 | FY2026 |
Other recipients under Q301 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826N0684 | VERACYTE, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $49,730 | FY2026 |
| 36C24826P0831 | UNIVERSITY OF MIAMI | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $178,265 | FY2026 |
| 36C24826N0548 | D & D LABORATORY LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $14,915 | FY2026 |
| 36C24826P0651 | ROCHE DIAGNOSTICS CORPORATION | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $239,858 | FY2026 |
| 36C24826P0221 | REPROSOURCE FERTILITY DIAGNOSTICS, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $27,500 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24816F0981_3600_GS07F5934R_4730 · retrieved 2026-09-26.